| Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis W Liu, Y Chen, MA Golan, ML Annunziata, J Du, U Dougherty, J Kong, ... The Journal of clinical investigation 123 (9), 3983-3996, 2013 | 332 | 2013 |
| Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis JR Pekow, AK Bhan, H Zheng, RT Chung Cancer 109 (12), 2490-2496, 2007 | 226 | 2007 |
| MicroRNAs in inflammatory bowel disease JR Pekow, JH Kwon Inflammatory bowel diseases 18 (1), 187-193, 2012 | 172 | 2012 |
| The emerging role of miRNAs in inflammatory bowel disease: a review CG Chapman, J Pekow Therapeutic advances in gastroenterology 8 (1), 4-22, 2015 | 169 | 2015 |
| Zinc deficiency is associated with poor clinical outcomes in patients with inflammatory bowel disease S Siva, DT Rubin, G Gulotta, K Wroblewski, J Pekow Inflammatory Bowel Diseases 23 (1), 152-157, 2017 | 148 | 2017 |
| EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators H Zhu, U Dougherty, V Robinson, R Mustafi, J Pekow, S Kupfer, YC Li, ... Molecular cancer research 9 (7), 960-975, 2011 | 148 | 2011 |
| miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes JR Pekow, U Dougherty, R Mustafi, H Zhu, M Kocherginsky, DT Rubin, ... Inflammatory bowel diseases 18 (1), 94-100, 2012 | 147 | 2012 |
| Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 143 | 2021 |
| The features of mucosa‐associated microbiota in primary sclerosing cholangitis J Torres, X Bao, A Goel, JF Colombel, J Pekow, B Jabri, KM Williams, ... Alimentary pharmacology & therapeutics 43 (7), 790-801, 2016 | 137 | 2016 |
| Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis JR Pekow, JT Hetzel, JA Rothe, SB Hanauer, JR Turner, J Hart, ... Inflammatory bowel diseases 16 (8), 1352-1356, 2010 | 103 | 2010 |
| Real-world experience with tofacitinib in IBD at a tertiary center R Weisshof, M Aharoni Golan, PH Sossenheimer, K El Jurdi, JE Ollech, ... Digestive diseases and sciences 64, 1945-1951, 2019 | 101 | 2019 |
| Risk of postoperative complications among inflammatory bowel disease patients treated preoperatively with vedolizumab A Yamada, Y Komaki, N Patel, F Komaki, AS Aelvoet, AL Tran, J Pekow, ... Official journal of the American College of Gastroenterology| ACG 112 (9 …, 2017 | 100 | 2017 |
| Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia CC Chen, J Pekow, V Llado, M Kanneganti, CW Lau, A Mizoguchi, ... The American journal of pathology 179 (3), 1494-1503, 2011 | 99 | 2011 |
| Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis K Meckel, YC Li, J Lim, M Kocherginsky, C Weber, A Almoghrabi, X Chen, ... The American journal of clinical nutrition 104 (1), 113-120, 2016 | 95 | 2016 |
| A human tissue map of 5-hydroxymethylcytosines exhibits tissue specificity through gene and enhancer modulation XL Cui, J Nie, J Ku, U Dougherty, DC West-Szymanski, F Collin, ... Nature communications 11 (1), 6161, 2020 | 94 | 2020 |
| Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis MA Sofia, MA Ciorba, K Meckel, CK Lim, GJ Guillemin, CR Weber, ... Inflammatory bowel diseases 24 (7), 1471-1480, 2018 | 93 | 2018 |
| Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the … B Christensen, D Micic, PR Gibson, A Yarur, E Bellaguarda, P Corsello, ... Alimentary pharmacology & therapeutics 47 (6), 753-762, 2018 | 81 | 2018 |
| miR-193a-3p is a key tumor suppressor in ulcerative colitis–associated colon cancer and promotes carcinogenesis through upregulation of IL17RD J Pekow, K Meckel, U Dougherty, Y Huang, X Chen, A Almoghrabi, ... Clinical Cancer Research 23 (17), 5281-5291, 2017 | 77 | 2017 |
| Safety of tofacitinib in a real-world cohort of patients with ulcerative colitis P Deepak, QA Alayo, A Khatiwada, B Lin, M Fenster, C Dimopoulos, ... Clinical Gastroenterology and Hepatology 19 (8), 1592-1601. e3, 2021 | 76 | 2021 |
| Fecal calprotectin in assessing endoscopic and histological remission in patients with ulcerative colitis WY Mak, A Buisson, MJ Andersen, D Lei, J Pekow, RD Cohen, SA Kahn, ... Digestive diseases and sciences 63, 1294-1301, 2018 | 76 | 2018 |
